Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
In relation to Commission Implementing Regulation (EU) 2024/2174 of 2 September 2024 laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council […]
JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of
JAZMP AVAILABLE TO ACT AS REFERENCE MEMBER STATE (RMS) IN MRP AND DCP PROCEDURES Read More »
JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of
JAZMP AVAILABLE TO ACT AS REFERENCE MEMBER STATE (RMS) IN MRP AND DCP PROCEDURES Read More »
The United Kingdom (UK) submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. Following
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) calls again on the Marketing Authorisation Holders to provide information about product codes (PC) used in unique
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
The stabilisation period in Slovenia, introduced after the implementation of Commission Delegated Regulation 2016/161, ended on 1st of December 2019. Therefore the Agency for Medicinal Products and Medical Devices of
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
Before the implementation of Commission Delegated Regulation 2016/161 the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia calls on the marketing authorisation holders to provide information
Call on marketing authorisation holders to provide information about product codes (PC) Read More »
